UniProt ID | FCG2C_HUMAN | |
---|---|---|
UniProt AC | P31995 | |
Protein Name | Low affinity immunoglobulin gamma Fc region receptor II-c | |
Gene Name | FCGR2C | |
Organism | Homo sapiens (Human). | |
Sequence Length | 323 | |
Subcellular Localization |
Isoform IIC4: Cytoplasm . Isoform IIC3: Cell membrane Single-pass type I membrane protein. Isoform IIC2: Cell membrane Single-pass type I membrane protein. Isoform IIC1: Cell membrane Single-pass type I membrane protein. |
|
Protein Description | Receptor for the Fc region of complexed immunoglobulins gamma. Low affinity receptor. Involved in a variety of effector and regulatory functions such as phagocytosis of immune complexes and modulation of antibody production by B-cells.. | |
Protein Sequence | MGILSFLPVLATESDWADCKSPQPWGHMLLWTAVLFLAPVAGTPAAPPKAVLKLEPQWINVLQEDSVTLTCRGTHSPESDSIQWFHNGNLIPTHTQPSYRFKANNNDSGEYTCQTGQTSLSDPVHLTVLSEWLVLQTPHLEFQEGETIVLRCHSWKDKPLVKVTFFQNGKSKKFSRSDPNFSIPQANHSHSGDYHCTGNIGYTLYSSKPVTITVQAPSSSPMGIIVAVVTGIAVAAIVAAVVALIYCRKKRISANSTDPVKAAQFEPPGRQMIAIRKRQPEETNNDYETADGGYMTLNPRAPTDDDKNIYLTLPPNDHVNSNN | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
106 | N-linked_Glycosylation | YRFKANNNDSGEYTC EEEECCCCCCCCEEE | 44.63 | UniProtKB CARBOHYD | |
180 | N-linked_Glycosylation | KFSRSDPNFSIPQAN CCCCCCCCCCCCCCC | 48.57 | UniProtKB CARBOHYD | |
187 | N-linked_Glycosylation | NFSIPQANHSHSGDY CCCCCCCCCCCCCCC | 31.76 | 23744091 | |
246 | Phosphorylation | AAVVALIYCRKKRIS HHHHHHHHHHHCCCC | 6.25 | 22817900 | |
261 | Ubiquitination | ANSTDPVKAAQFEPP CCCCCCCHHHHCCCC | 43.31 | - | |
277 | Acetylation | RQMIAIRKRQPEETN CEEEEEECCCCCCCC | 49.63 | 7708235 | |
287 | Phosphorylation | PEETNNDYETADGGY CCCCCCCCCCCCCCE | 19.80 | 8756631 | |
289 | Phosphorylation | ETNNDYETADGGYMT CCCCCCCCCCCCEEE | 24.66 | - | |
294 | Phosphorylation | YETADGGYMTLNPRA CCCCCCCEEEECCCC | 7.77 | 18083107 | |
296 | Phosphorylation | TADGGYMTLNPRAPT CCCCCEEEECCCCCC | 18.20 | - | |
303 | Phosphorylation | TLNPRAPTDDDKNIY EECCCCCCCCCCCEE | 51.59 | - | |
310 | Phosphorylation | TDDDKNIYLTLPPND CCCCCCEEEECCCCC | 11.74 | 21082442 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
287 | Y | Phosphorylation | Kinase | SYK | P43405 | PSP |
287 | Y | Phosphorylation | Kinase | SYK | Q15046 | PhosphoELM |
294 | Y | Phosphorylation | Kinase | SRC-FAMILY | - | GPS |
294 | Y | Phosphorylation | Kinase | SRC-TYPE TYR-KINASES | - | Uniprot |
310 | Y | Phosphorylation | Kinase | BLK | P51451 | PSP |
310 | Y | Phosphorylation | Kinase | FYN | P39688 | PSP |
310 | Y | Phosphorylation | Kinase | SYK | P43405 | PSP |
310 | Y | Phosphorylation | Kinase | LYN | P07948 | PSP |
310 | Y | Phosphorylation | Kinase | LYN | P25911 | PSP |
310 | Y | Phosphorylation | Kinase | SRC-FAMILY | - | GPS |
310 | Y | Phosphorylation | Kinase | SRC-TYPE TYR-KINASES | - | Uniprot |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of FCG2C_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of FCG2C_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
Oops, there are no PPI records of FCG2C_HUMAN !! |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Phosphorylation | |
Reference | PubMed |
"Global survey of phosphotyrosine signaling identifies oncogenickinases in lung cancer."; Rikova K., Guo A., Zeng Q., Possemato A., Yu J., Haack H., Nardone J.,Lee K., Reeves C., Li Y., Hu Y., Tan Z., Stokes M., Sullivan L.,Mitchell J., Wetzel R., Macneill J., Ren J.M., Yuan J.,Bakalarski C.E., Villen J., Kornhauser J.M., Smith B., Li D., Zhou X.,Gygi S.P., Gu T.-L., Polakiewicz R.D., Rush J., Comb M.J.; Cell 131:1190-1203(2007). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-310, AND MASSSPECTROMETRY. | |
"In vivo and in vitro specificity of protein tyrosine kinases forimmunoglobulin G receptor (FcgammaRII) phosphorylation."; Bewarder N., Weinrich V., Budde P., Hartmann D., Flaswinkel H.,Reth M., Frey J.; Mol. Cell. Biol. 16:4735-4743(1996). Cited for: PHOSPHORYLATION AT TYR-294 AND TYR-310. |